Skip to content

HIV most often passed on by younger gay men who have undiagnosed HIV, are not on treatment, and have an ongoing partnership

HIV has become more virulent over time, not less, European study finds

Sofosbuvir/ledipasvir cures most previously treated hepatitis C patients with cirrhosis

Marc Bourliere speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

Poor weight gain during first year of ART associated with increased mortality risk for children with HIV in resource-limited settings

European HIV response "falling behind" as Eastern European epidemic grows

Reduced physical function significantly increases mortality risk of middle-aged people living with HIV

Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection

Sofosbuvir/ledipasvir with ribavirin cures most people with hepatitis C recurrence after liver transplantation

Sofosbuvir + simeprevir shows good results for hepatitis C in real-world use

Donald Jensen speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.